Conference Coverage Archives

Before COVID19 - The AACR 2019 Annual Meeting during the opening plenary session at the American Association for Cancer Research Annual Meeting at the Georgia World Congress Center. Photo Courtesy: © AACR/Todd Buchanan.

AACR 2020: Phase I Study of COM701 Demonstrates Anti-tumor Activity in...

Peter Hofland, Ph.D - April 28, 2020

The American Association for Cancer Research (AACR) Annual Meeting in pre-COVID19 Days: New Orleans, LA - The AACR 2016 Annual Meeting. Photo courtesy AACR/Scott Morgan.

STRO-002 Shows Encouraging Results in Phase I Trial in Treatment of...

Peter Hofland, Ph.D - April 27, 2020

In better times: the AACR annual meeting opening plenary session in 2018 at the McCormick Convention Center in Chicago, Illinois with the 2019 president-elect Elaine Mardis, Ph.D, who served as program committee chair for this 2018 meeting, addressed attendees. Photo Courtesy © AACR/Todd Buchanan.

Study Shows Inhibition of the Menin-MLL1 Interaction to Induce a Response...

Danielle Garcia - April 27, 2020

Drug Combination Demonstrates Significant Improved pCR in High Risk HER2-negative Breast...

Editorial Team - April 27, 2020

General views of the 55th Annual Meeting of the American Association of Clinical Oncology (ASCO) - held in the McCormick Place in Chicago, Ill. Courtesy: 2019. ASCO/Luke Franke 2019.

ASCO Goes Virtual; World Conference on Lung Cancer Postponed

Peter Hofland, Ph.D - March 25, 2020

Annual Meeting of the AACR Among Growing Number of Conferences to...

Editorial Team - March 10, 2020

Nivolumab + ipilimumab Shows Continued Survival in Patients with Metastatic Renal...

Peter Hofland, Ph.D - February 15, 2020

U.S. FDA Accepts Priority Review for Lisocabtagene Maraleucel R/R Large...

Editorial Team - February 14, 2020

Enfortumab Vedotin + Pembrolizumab Shrink Tumors in the Majority of Bladder...

Peter Hofland, Ph.D - February 11, 2020

Physician consulting with a patients in hospital exam room.

Onvasertib: Confirmed Tumor Regression + Clinical Benefit in KRAS-Mutated mCRC

Peter Hofland, Ph.D - January 29, 2020

12 3...30 Page 1 of 30

LATEST NEWS

Public-private Partnership to Improve Outcomes for Veterans at Risk of Lung Cancer

Danielle Garcia - June 16, 2020

Press Releases | Cancer

Reaction from Cory Watson Attorneys: $10 Billion Settlement Reached in... July 1, 2020
Bayer, the maker of weed killer Roundup, will pay more than $10 billion to resolve thousands of lawsuits regarding claims that its product causes cancer. Monsanto lost its first three Roundup trials...(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/reaction_from_cory_watson_attorneys_10_billion_settlement_reached_in_roundup_weed_killer_cancer_litigation/prweb17229746.htm
Silicon Beach-Based Nonprofit Startup Cure Glioblastoma Launches... July 1, 2020
Internal research programs to focus on building combination immunotherapies for brain cancer(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/silicon_beach_based_nonprofit_startup_cure_glioblastoma_launches_laboratory_operations_and_appoints_drs_john_boockvar_and_lisa_haile_as_senior_fellows/prweb17226957.htm
Lumeda Announces Formation of its Scientific Advisory Board July 1, 2020
Prominent medical and scientific experts to help company advance development of PDT products.(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/lumeda_announces_formation_of_its_scientific_advisory_board/prweb17222019.htm
Latest Data on IO Combinations Will Be Announced at the IO... June 30, 2020
IO Combinations 360°, organized by the Conference Forum, a combination-specific program, reports on the latest data and advancements to expedite more accurate therapies for patients faster taking...(PRWeb June 30, 2020)Read the full story at https://www.prweb.com/releases/latest_data_on_io_combinations_will_be_announced_at_the_io_combinations_360_conference_october_1_2_2020/prweb17225687.htm
Flagship Biosciences Launches New Clinical Diagnostics Service June 30, 2020
TissueInsight Immuno-Oncology Service Offers Data for Advanced Cancer Patient Care(PRWeb June 30, 2020)Read the full story at https://www.prweb.com/releases/flagship_biosciences_launches_new_clinical_diagnostics_service/prweb17223687.htm
AltruBio Inc. presented AbGn-107 Phase 1a chemo-refractory GI cancer... June 29, 2020
AltruBio Inc. http://www.altrubio.com, a clinical stage biotech company, has announced the presentation of AbGn-107 at the 2020 ASCO GI Cancer...(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/altrubio_inc_presented_abgn_107_phase_1a_chemo_refractory_gi_cancer_results_at_asco_gi_2020/prweb17222550.htm
Dimensional Insight Announces Registration Sponsorship of St. Jude... June 29, 2020
Event benefits kids with childhood cancer, other life-threatening diseases at St. Jude Children’s Research Hospital(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/dimensional_insight_announces_registration_sponsorship_of_st_jude_walk_run_boston/prweb17222315.htm
iRECIST Criteria: An Operational Approach in Oncology Clinical Trials,... June 29, 2020
In this free webinar, the featured speakers will discuss concepts of establishing iUPD and iCPD by category and data scenarios across imaging time point visits. Attendees will learn about image case...(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/irecist_criteria_an_operational_approach_in_oncology_clinical_trials_upcoming_webinar_hosted_by_xtalks/prweb17222231.htm
The Lymphoma Research Foundation Hosts Inaugural Swirl: America, An At... June 29, 2020
LRF Spokesperson and Acclaimed Journalist Lisa Guerrero Kicks Off Nationwide Cheeseboard Challenge to Drive Lymphoma Awareness(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/the_lymphoma_research_foundation_hosts_inaugural_swirl_america_an_at_home_tasting_virtual_fundraiser/prweb17222149.htm
Managing Abnormal Results on Cervical Cancer Screening: ASCCP Issues... June 28, 2020
Published in Journal of Lower Genital Tract Disease, New Recommendations Focus on More Personalized Risk Assessment and Management(PRWeb June 28, 2020)Read the full story at https://www.prweb.com/releases/managing_abnormal_results_on_cervical_cancer_screening_asccp_issues_updated_guidelines/prweb17219257.htm
New US Patent Protects Key Element of First-in-Class Prodrug Candidate... June 26, 2020
Tumor-targeting and tumor-penetrating peptide enables EnduRx Pharmaceuticals novel prodrug for triple-negative breast cancer(PRWeb June 26, 2020)Read the full story at https://www.prweb.com/releases/new_us_patent_protects_key_element_of_first_in_class_prodrug_candidate_for_triple_negative_breast_cancer/prweb17214155.htm
PathAI and Bristol Myers Squibb find positive association of digital... June 26, 2020
Digital analysis shows higher sensitivity for PD-L1 expression and accurate detection of low-level PD-L1 expression in patients compared to manual reading(PRWeb June 26, 2020)Read the full story at https://www.prweb.com/releases/pathai_and_bristol_myers_squibb_find_positive_association_of_digital_pd_l1_expression_with_outcomes_in_nivolumab_treated_patients_in_an_exploratory_analysis/prweb17220807.htm
Lumeda Enters License Agreement with Roswell Park Comprehensive Cancer... June 25, 2020
Company secures exclusive rights for intraoperative photodynamic therapy in the treatment of non-small cell lung cancer(PRWeb June 25, 2020)Read the full story at https://www.prweb.com/releases/lumeda_enters_license_agreement_with_roswell_park_comprehensive_cancer_center/prweb17218726.htm
Texas Breast Cancer Survivor Launches Experiential Website to Help... June 25, 2020
It would take Stage 3 Breast Cancer in 2011 for Stephanie Johnson to consider cannabis. Now, having survived longer than anticipated, she hopes to help others feel more comfortable, too.(PRWeb June 25, 2020)Read the full story at https://www.prweb.com/releases/texas_breast_cancer_survivor_launches_experiential_website_to_help_others_searching_for_quality_hemp_cbd_information/prweb17211906.htm

Conference Coverage

New Therapies may Offer Hope for Patients with Metastatic Breast Cancer

ASCO 2020: Oncoceutics’ ONC201 Demonstrates Clinical Benefit

FORWARD II Trial of Mirvetuximab Soravtansine + Bevacizumab Demonstrates Encouraging Outcomes

What to Expect at ASCO 2020: GSK’s Transformational Medicines

AACR 2020: First-in-human Clinical Trial for Universal TruUCAR™ GC027 in R/R T-cell ALL

AACR 2020: Phase I Study of COM701 Demonstrates Anti-tumor Activity in...

STRO-002 Shows Encouraging Results in Phase I Trial in Treatment of...

Study Shows Inhibition of the Menin-MLL1 Interaction to Induce a Response...

Drug Combination Demonstrates Significant Improved pCR in High Risk HER2-negative Breast...

ASCO Goes Virtual; World Conference on Lung Cancer Postponed

Annual Meeting of the AACR Among Growing Number of Conferences to...

Nivolumab + ipilimumab Shows Continued Survival in Patients with Metastatic Renal...

U.S. FDA Accepts Priority Review for Lisocabtagene Maraleucel R/R Large...

Enfortumab Vedotin + Pembrolizumab Shrink Tumors in the Majority of Bladder...

Onvasertib: Confirmed Tumor Regression + Clinical Benefit in KRAS-Mutated mCRC

LATEST NEWS

Positive CHMP Opinion for Samsung Bioepis’ Bevacizumab Biosimilar Candidate

New Therapies may Offer Hope for Patients with Metastatic Breast Cancer

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

AACR 2020: Positive Preclinical Safety and Efficacy Data for TXR-311 in HCC

Public-private Partnership to Improve Outcomes for Veterans at Risk of Lung Cancer

Positive CHMP Opinion for Samsung Bioepis’ Bevacizumab Biosimilar Candidate

New Therapies may Offer Hope for Patients with Metastatic Breast Cancer

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...